Scott D. Corley

TL;DR: Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate -control strategy.

TL;DR: An “on-treatment” analysis of the relationship of survival to cardiac rhythm and treatment as they changed over time suggests that any beneficial antiarrhythmic effects of AADs are offset by their adverse effects.

TL;DR: The CASS Registry contains 912 patients with LMEQ disease, defined as combined stenoses of ≥70% in the proximal left anterior descending coronary artery before the first septal perfo... as mentioned in this paper.

TL;DR: Stroke rates were not significantly different in the rate control and sinus rhythm control arms, however, several clinical and therapeutic variables were associated with stroke risk.

TL;DR: Bleeding is a significant problem that complicates management of patients with atrial fibrillation, and risk factors for bleeding can be identified and knowledge of these risk factors can be used to plan therapy.